The Avastin Question and the Payor Community
Links shared publicly online about this topic.
- 557total visits
The Avastin Question and the Payor Community
nccn.org —
The U.S. Food and Drug Administration's (FDA) recent announcement that it is recommending removing approval for use of Avastin® (bevacizumab) for the treatment of metastatic breast cancer has generated considerable interest and strong opinions.Informed and concerned people view the decision differently:the FDA's decision is endorsed by some oncologists and patient advocacy groups and condemned by others.If the FDA affirms its decision upon appeal, then organizations that pay claims - commerc
View full resource at nccn.org
Tags: Cancer, Breast Cancer, Colorectal Cancer Medication, Diet and Nutrition, Women's Health, FDA, Avastin
Most Recently Shared on January 24, 2011 at 4:13 pm By:
Breast cancer and Avastin (bevacizumab): NCCN vs FDA. http://www.nccn.org/about/news/ebulletin/2011-01-24/avastin.asp
Advertisement
